Invivo Therapeutics Holdings Corp Major Shareholder Francis Reynolds Sells 36,000 Shares (NVIV)
Invivo Therapeutics Holdings Corp (NASDAQ:NVIV) major shareholder Francis Reynolds unloaded 36,000 shares of Invivo Therapeutics Holdings Corp stock in a transaction that occurred on Tuesday, December 31st. The stock was sold at an average price of $2.25, for a total transaction of $81,000.00. Following the sale, the insider now directly owns 10,235,920 shares in the company, valued at approximately $23,030,820. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Major shareholders that own at least 10% of a company’s stock are required to disclose their transactions with the SEC.
Shares of Invivo Therapeutics Holdings Corp (NASDAQ:NVIV) traded down 2.35% during mid-day trading on Thursday, hitting $2.242. 94,944 shares of the company’s stock traded hands. Invivo Therapeutics Holdings Corp has a 52-week low of $0.94 and a 52-week high of $6.20. The stock’s 50-day moving average is $1.85 and its 200-day moving average is $2.61. The company’s market cap is $176.5 million.
Separately, analysts at Aegis cut their price target on shares of Invivo Therapeutics Holdings Corp from $7.00 to $4.00 in a research note to investors on Monday, November 25th. They now have a “buy” rating on the stock.
InVivo Therapeutics Holdings Corp., formerly Design Source, Inc is a development-stage company. The Company is developing and commercializing technologies for the treatment of spinal cord injuries.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.